OrthoPediatrics
Leading Innovation in Pediatric Orthopedics
Leading Innovation in Pediatric Orthopedics
OrthoPediatrics is a pioneering company in pediatric orthopedics, dedicated to providing anatomically appropriate implants to help children with orthopedic conditions and injuries. The company's unwavering commitment is evident in its daily focus on advancing pediatric orthopedics through innovative technologies and high-quality products.
Since its establishment in 2006, OrthoPediatrics has been expanding its offerings to include all necessary implants and instruments for pediatric orthopedic surgeons. Specializing in Long Bone Deformity Correction & Trauma, Scoliosis, and Sports Medicine/Soft Tissue Repair, the company caters to the specific needs of its young patients.
OrthoPediatrics made a significant step by becoming a publicly traded company on Nasdaq under the symbol "KIDS" on October 12, 2017. This move showcased the company's growth and potential in the market.
The latest investment of $80.00M in post-IPO debt was secured on January 08, 2024, with MidCap Financial as the investor. This substantial investment underscores the confidence in OrthoPediatrics and its future trajectory. With its base in the United States, OrthoPediatrics continues to seek talented professionals to join its devoted team as it forges ahead in the field of pediatric orthopedics.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Post-IPO Debt | $80.00M | 1 |
|
08 Jan 2024 |
| Post-IPO Equity | $125.00M | - | 10 Aug 2022 | |
| Venture Round | $38.90M | - | 03 Jun 2014 | |
| Series A | $51.88K | - | 18 Jun 2010 | |
| Debt Financing | $12.50M | - | 13 Jan 2008 |
No recent news or press coverage available for OrthoPediatrics.
We care about your data, and we'd love to use cookies make your experience better.
